UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 242

Sortiert nach

Targeted therapies for renal cell carcinoma

Nature reviews. Nephrology, 2017-08, Vol.13 (8), p.496

2017

Volltextzugriff (PDF)

Disparities in Cancer Care and the Asian American Population

The oncologist (Dayton, Ohio), 2021-06, Vol.26 (6), p.453-460

2021

Volltextzugriff (PDF)

Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming

The Journal of clinical investigation, 2018-10, Vol.128 (10), p.4472-4484

2018

Volltextzugriff (PDF)

Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer

European urology, 2021-06, Vol.79 (6), p.762-771

2021

Volltextzugriff (PDF)

Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma

Journal of extracellular vesicles, 2018-12, Vol.7 (1), p.1505403-n/a

2018

Volltextzugriff (PDF)

MYC Mediates Large Oncosome-Induced Fibroblast Reprogramming in Prostate Cancer

Cancer research (Chicago, Ill.), 2017-05, Vol.77 (9), p.2306-2317

2017

Volltextzugriff (PDF)

MAOA-Dependent Activation of Shh-IL6-RANKL Signaling Network Promotes Prostate Cancer Metastasis by Engaging Tumor-Stromal Cell Interactions

Cancer cell, 2017-03, Vol.31 (3), p.368-382

2017

Volltextzugriff (PDF)

COVID-19 and androgen-targeted therapy for prostate cancer patients

Endocrine-related cancer, 2020-09, Vol.27 (9), p.R281-R292

2020

Volltextzugriff (PDF)

Loss of testosterone impairs anti-tumor neutrophil function

Nature communications, 2020-03, Vol.11 (1), p.1613-1613, Article 1613

2020

Volltextzugriff (PDF)

Fyn: a novel molecular target in cancer

Cancer, 2010-04, Vol.116 (7), p.1629-1637

2010

Volltextzugriff (PDF)

Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide–Drug Conjugate

Journal of medicinal chemistry, 2018-03, Vol.61 (5), p.2052-2061

2018

Volltextzugriff (PDF)

Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment

Cell metabolism, 2023-07, Vol.35 (7), p.1209-1226.e13

2023

Volltextzugriff (PDF)

miR-409-3p/-5p Promotes Tumorigenesis, Epithelial-to-Mesenchymal Transition, and Bone Metastasis of Human Prostate Cancer

Clinical cancer research, 2014-09, Vol.20 (17), p.4636-4646

2014

Volltextzugriff (PDF)

Great kindness from a giant: scientist, friend, and mentor-preface of the special issue in memoriam and celebration of Leland W.K. Chung, Ph.D. (1940-2021) from special issue senior guest editor(s)

American journal of clinical and experimental urology, 2021-08, Vol.9 (4), p.248-250

Posadas, Edwin M

2021

Volltextzugriff (PDF)

NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells

Advanced drug delivery reviews, 2018-02, Vol.125, p.78-93

2018

Volltextzugriff (PDF)

Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity

Journal of clinical oncology, 2008-08, Vol.26 (22), p.3709-3714

2008

Volltextzugriff (PDF)

Brain Metastases in Renal Cell Carcinoma: Immunotherapy Responsiveness Is Multifactorial and Heterogeneous

Journal of clinical oncology, 2019-08, Vol.37 (23), p.1987-1989

2019

Volltextzugriff (PDF)

Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical Trial

JAMA oncology, 2018-10, Vol.4 (10), p.1344

2018

Volltextzugriff (PDF)

Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

Clinical cancer research, 2021-03, Vol.27 (6), p.1623-1630

2021

Volltextzugriff (PDF)

Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation

Cancer immunology, immunotherapy, 2024-04, Vol.73 (6), p.110-110, Article 110

2024

Volltextzugriff (PDF)

miR-154 and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer

Clinical cancer research, 2014-12, Vol.20 (24), p.6559-6569

2014

Volltextzugriff (PDF)

NanoVelcro Chip for CTC enumeration in prostate cancer patients

Methods (San Diego, Calif.), 2013-12, Vol.64 (2), p.144-152

2013

Volltextzugriff (PDF)

Intensification of Androgen Deprivation Therapy in High-Risk, Nonmetastatic Prostate Cancer: Lessons From STAMPEDE

JNCI cancer spectrum, 2022-07, Vol.6 (4)

2022

Volltextzugriff (PDF)

Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer

PloS one, 2014-02, Vol.9 (2), p.e88967-e88967

2014

Volltextzugriff (PDF)

A practical guide for assessing and managing cardiovascular risk during androgen‐deprivation therapy in patients with prostate cancer

Cancer, 2024-06, Vol.130 (11), p.1916-1929

2024

Volltextzugriff (PDF)

1 – 25 von 242

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(230)
Mit Volltextzugriff
(216)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(123)
Life Sciences & Biomedicine
(114)
Humans
(97)
Male
(74)
Oncology
(68)
Prostate Cancer
(59)
Urology & Nephrology
(31)
Aged
(30)
Prostatic Neoplasms - Pathology
(28)
Middle Aged
(27)
Tumors
(27)
Metastasis
(20)
Aged, 80 And Over
(18)
Antineoplastic Agents - Therapeutic Use
(18)
Prostatic Neoplasms - Drug Therapy
(17)
Animals
(16)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Urology
(16)
Cancer
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(54)
Cancer Research
(23)
Cancer
(13)
The Journal Of Urology
(12)
Clinical Cancer Research
(11)
European Urology
(6)
Urology
(5)
American Journal Of Clinical And Experimental Urology
(4)
Oncology
(4)
Oncotarget
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Targeted therapies for renal cell carcinoma

Disparities in Cancer Care and the Asian American Population

Stromal epigenetic alterations drive metabolic and neuroendocrine prostate cancer reprogramming

Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer

Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma

MYC Mediates Large Oncosome-Induced Fibroblast Reprogramming in Prostate Cancer

MAOA-Dependent Activation of Shh-IL6-RANKL Signaling Network Promotes Prostate Cancer Metastasis by Engaging Tumor-Stromal Cell Interactions

COVID-19 and androgen-targeted therapy for prostate cancer patients

Loss of testosterone impairs anti-tumor neutrophil function

Fyn: a novel molecular target in cancer

Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide–Drug Conjugate

Extracellular vesicles in fatty liver promote a metastatic tumor microenvironment

miR-409-3p/-5p Promotes Tumorigenesis, Epithelial-to-Mesenchymal Transition, and Bone Metastasis of Human Prostate Cancer

Great kindness from a giant: scientist, friend, and mentor-preface of the special issue in memoriam and celebration of Leland W.K. Chung, Ph.D. (1940-2021) from special issue senior guest editor(s)

NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells

Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity

Brain Metastases in Renal Cell Carcinoma: Immunotherapy Responsiveness Is Multifactorial and Heterogeneous

Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical Trial

Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer

Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation

miR-154 and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer

NanoVelcro Chip for CTC enumeration in prostate cancer patients

Intensification of Androgen Deprivation Therapy in High-Risk, Nonmetastatic Prostate Cancer: Lessons From STAMPEDE

Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer

A practical guide for assessing and managing cardiovascular risk during androgen‐deprivation therapy in patients with prostate cancer

Suchergebnisse filtern